Article Versions Notes

Arslan A, Yet B, Nemutlu E, Akdağ Çaylı Y, Eroğlu H, Öner L. Celecoxib Nanoformulations with Enhanced Solubility, Dissolution Rate, and Oral Bioavailability: Experimental Approaches over In Vitro/In Vivo Evaluation. Pharmaceutics. 2023; 15(2):363. https://doi.org/10.3390/pharmaceutics15020363

Arslan, Aslıhan, Barbaros Yet, Emirhan Nemutlu, Yağmur Akdağ Çaylı, Hakan Eroğlu, and Levent Öner. 2023. "Celecoxib Nanoformulations with Enhanced Solubility, Dissolution Rate, and Oral Bioavailability: Experimental Approaches over In Vitro/In Vivo Evaluation" Pharmaceutics 15, no. 2: 363. https://doi.org/10.3390/pharmaceutics15020363

Arslan, A., Yet, B., Nemutlu, E., Akdağ Çaylı, Y., Eroğlu, H., & Öner, L. (2023). Celecoxib Nanoformulations with Enhanced Solubility, Dissolution Rate, and Oral Bioavailability: Experimental Approaches over In Vitro/In Vivo Evaluation. Pharmaceutics, 15(2), 363. https://doi.org/10.3390/pharmaceutics15020363